午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ATR-IN-23

ATR-IN-23 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:ATR-IN-23
CAS:2923800-62-6
Package:50mg;1980USD|25mg;1520USD|100mg;2500USD
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Products Intro: Product Name:ATR-IN-23
CAS:2923800-62-6
Package:50mg/RMB 13800;25mg/RMB 10600;100mg/RMB 17500

ATR-IN-23 manufacturers

  • ATR-IN-23
  • ATR-IN-23 pictures
  • $1980.00 / 50mg
  • 2025-04-30
  • CAS:2923800-62-6
  • Min. Order:
  • Purity:
  • Supply Ability: 10g
ATR-IN-23 Basic information
Product Name:ATR-IN-23
Synonyms:ATR-IN-23;1H-Benzimidazol-2-amine, N-methyl-1-[4-[(3R)-3-methyl-4-morpholinyl]-7-(methylsulfonyl)thieno[3,2-d]pyrimidin-2-yl]-
CAS:2923800-62-6
MF:C20H22N6O3S2
MW:458.56
EINECS:
Product Categories:
Mol File:2923800-62-6.mol
ATR-IN-23 Structure
ATR-IN-23 Chemical Properties
Boiling point 765.622±70.00 °C(Press: 760.00 Torr)(predicted)
density 1.577±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka5.767±0.10(predicted)
Safety Information
MSDS Information
ATR-IN-23 Usage And Synthesis
UsesATR-IN-23 (Compound 34) is a potent and selective ATR inhibitor with an IC50 of 1.5 nM. ATR-IN-23 has potent antiproliferative effects on LoVo cells and synthetic lethality on HT-29 cells, and can be used in the study of DNA damage response (DDR)-deficient cancers[1].
in vivo

ATR-IN-23 shows acute toxicity at a maximum concentration of 2000 mg/kg and possesses moderate safety in ICR mice[1].
ATR-IN-23 (50 mg/kg; once a day or twice a day; p.o.; 21 days) exhibits moderate antitumor efficacy in BALB/c nude mice[1].

Animal Model:BALB/c nude mice[1]
Dosage:50 mg/kg
Administration:p.o., once a day or twice a day for 21 consecutive days, dissolved in a solution of DMSO (10%), solutol (10%), and saline (80%)
Result:Exhibited moderate antitumor efficacy, with a tumor growth inhibition (TGI) value of 55% at dosages of 50 mg/kg twice a day.
References[1] Duan Y, et al. Discovery of Thieno[3,2-d]pyrimidine derivatives as potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) kinase. Eur J Med Chem. 2023 Jul 5;255:115370. DOI:10.1016/j.ejmech.2023.115370
ATR-IN-23 Preparation Products And Raw materials
Tag:ATR-IN-23(2923800-62-6) Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.